Bradley Roby

Cornerback

Age: 28
Free Agency: 2023 (UFA)
Accrued Seasons: 6
  • 2020 Salary Cap Charge: $9,312,500 (4.27% of cap)
  • 2020 Cash Payout: $11,500,000 (4.60% of spending)
  • 2020 Cash to Cap Ratio: 1.23
  • Contract Value: $31,500,000 ($10,500,000 APY)
  • Fully Guaranteed Money: $19,000,000
  • Contract Ranking: 17/278 at CB

Current Contract

(UFA, signed 2020)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusRoster BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202028$4,500,000$1,000,000$3,500,000$500,000$8,000,000$9,312,5004.3%
202129$9,500,000$1,000,000$0$500,000$8,000,000$11,000,0006.0%
202230$9,500,000$1,000,000$0$500,000$0$11,000,0004.8%
Total$23,500,000$3,000,000$3,500,000$1,500,000$16,000,000$31,312,500

Contract Notes

Bradley Roby signed a three year contract with the Houston Texans on April 3, 2020.  Contract is worth $31.5 million with $19 million virtually guaranteed at signing.  Roby received a $3 million signing bonus, $4.5 million salary guarantee in 2020, $3.5 million roster bonus in 2020 (paid 5 days after signing), and $8 million salary guarantee in 2021.  Roby can earn up to $500,000 in each year of the contract via roster bonuses paid $31,250 per game active.
Career Earnings: $28,291,028
Career APY: $4,715,171
Potential Earnings: $56,791,028
Total Guarantees: $34,084,456
Largest Cash Payment: $11,500,000 (2020)
Largest Cap Number: $11,000,000 (2021)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
BroncosDraftedExpired20145$15,478,528$3,095,706$5,584,456$15,478,528100.0%$3,095,706
TexansUFAExpired20191$10,000,000$10,000,000$9,500,000$9,812,50098.1%$9,812,500
TexansUFAActive20203$31,500,000$10,500,000$19,000,000$3,000,0009.5%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Broncos5$15,478,528$3,095,706$15,478,5280.0%$00.0%
Texans1$12,812,500$12,812,500$9,968,7500.0%$00.0%

Salary Cap History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2014Broncos$420,000$844,096$0$0$420,000$1,264,0960.9%$3,796,384
2015Broncos$736,024$844,096$0$0$736,024$1,580,1201.1%$736,024
2016Broncos$1,052,048$844,096$0$0$1,052,048$1,896,1441.2%$1,052,048
2017Broncos$1,018,072$844,096$350,000$0$0$2,212,1681.3%$1,368,072
2018Broncos$8,526,000$0$0$0$8,526,000$8,526,0004.5%$8,526,000
2019Texans$5,000,000$4,500,000$0$500,000$5,000,000$9,968,7504.7%$9,812,500
2020Texans$4,500,000$1,000,000$3,500,000$500,000$8,000,000$9,312,5004.3%$11,500,000
2021Texans$9,500,000$1,000,000$0$500,000$8,000,000$11,000,0006.0%$10,000,000
2022Texans$9,500,000$1,000,000$0$500,000$0$11,000,0004.8%$10,000,000
Total$40,252,144$10,876,384$3,850,000$2,000,000$31,734,072$56,759,778$56,791,028

Statistics

YearGames PlayedGames MissedSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2014160074.5%16.9%632135113202230
2015160056.8%26.7%34600101011911211
2016160059.8%8.7%3451000821021002
2017160068.2%25.0%346101117101100
2018151085.9%0.9%455001012102000
2019106060.5%0.2%3531102182491001
202070085.8%0.0%26300105100000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$10,933,000$10,500,000
Injury Adjusted$10,933,000$10,500,000
test
OTC Valuation $3.1M $6.2M $9.3M $12.4M $15.5M APY $3.3M $6.7M $10.0M $13.3M $16.7M $6,132,000 $3,750,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.